Clinical Trial Update: Study Evaluating Venlafaxine Extended-Release in Depressed and Anxious Patients [Phase 4]

View source ↗

Summary

Phase 4 trial update indicating the venlafaxine extended-release study in anxious and depressed patients has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Major Depressive Disorder

Drugs mentioned

• Venlafaxine Extended-Release (venlafaxine)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Anxiety Disorders, Depression | Phase 4 | Status: COMPLETED